Our study indicates that loss of cDC1 reverses the immunosuppressive microenvironment and inhibits myeloma progression, suggesting that the presence of cDC1 is harmful in the middle phase of myeloma progression. This evidence concerns the gene MPPE1 and plasma cell myeloma.